» Authors » C G Kallenberg

C G Kallenberg

Explore the profile of C G Kallenberg including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 267
Citations 4770
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nienhuis H, de Leeuw K, Bijzet J, Smit A, Schalkwijk C, Graaff R, et al.
Rheumatology (Oxford) . 2008 Aug; 47(10):1554-8. PMID: 18701539
Objectives: To examine whether skin advanced glycation endproducts (AGEs) accumulation, plasma levels of AGEs-N(epsilon)-carboxymethyllysine (CML) and N(epsilon)-carboxyethyllysine (CEL)-and serum levels of soluble receptor for AGEs (sRAGE) are elevated in SLE...
2.
de Leeuw K, Graaff R, de Vries R, Dullaart R, Smit A, Kallenberg C, et al.
Rheumatology (Oxford) . 2007 Sep; 46(10):1551-6. PMID: 17848401
Objective: To investigate whether advanced glycation endproducts (AGEs) are increased in patients with systemic lupus erythematosus (SLE), and are related to atherosclerosis, which is accelerated in SLE, and its traditional...
3.
Ferreiro-Neira I, Calaza M, Alonso-Perez E, Marchini M, Scorza R, Sebastiani G, et al.
Genes Immun . 2007 Jun; 8(5):429-38. PMID: 17568788
Genetic variation in the interferon regulatory factor 5 (IRF5) gene affects systemic lupus erythematosus (SLE) susceptibility. However, association is complex and incompletely defined. We obtained fourteen European sample collections with...
4.
de Leeuw K, Freire B, Smit A, Bootsma H, Kallenberg C, Bijl M
Lupus . 2006 Nov; 15(10):675-82. PMID: 17120595
To determine risk factors of accelerated atherosclerosis in patients with systemic lupus erythematosus (SLE), 72 patients with inactive disease and 36 age- and sex-matched controls were included. The intima-media thickness...
5.
de Leeuw K, Sanders J, Stegeman C, Smit A, Kallenberg C, Bijl M
Ann Rheum Dis . 2004 Sep; 64(5):753-9. PMID: 15374854
Background: Several autoimmune disorders are complicated by excess cardiovascular disease. In addition to traditional risk factors, non-traditional risk factors such as endothelial activation and excessive vascular remodelling might be determinants...
6.
van Rossum A, Limburg P, Kallenberg C
Clin Exp Rheumatol . 2004 Jan; 21(6 Suppl 32):S64-8. PMID: 14740429
Antineutrophil cytoplasm autoantibody (ANCA)-associated small vessel vasculitides are systemic diseases characterized by chronic inflammation of blood vessels. These vasculitides are associated with the presence of ANCA which are, in most...
7.
Vissink A, Spijkervet F, Kalk W, van Nieuw Amerongen A, Bootsma H, Kallenberg C
Ned Tijdschr Tandheelkd . 2002 Apr; 104(12):458-62. PMID: 11923921
Sjögren's syndrome is an auto-immune disease involving exocrine glands causing amongst others xerostomia and dry eyes. Many other tissues may be affected as well. Early recognition of this disease may...
8.
Bijl M, Horst G, Limburg P, Kallenberg C
Lupus . 2002 Jan; 10(12):866-72. PMID: 11787876
Levels of apoptotic lymphocytes have been found to be increased in SLE and persistence of apoptotic cells has been associated with autoantibody production. Increased lymphocyte Fas (CD95) expression due to...
9.
Brons R, Kallenberg C, Tervaert J
Rheum Dis Clin North Am . 2001 Nov; 27(4):833-48. PMID: 11723767
The role of ICs in ANCA-associated vasculitides remains controversial. The ANCA-associated vasculitides are described as being pauci-immune. We hypothesize that the absence of ICs is a result of an exaggerated...
10.
Kalk W, Vissink A, Spijkervet F, Bootsma H, Kallenberg C, Nieuw Amerongen A
Ann Rheum Dis . 2001 Nov; 60(12):1110-6. PMID: 11709452
Background: The common occurrence of xerostomia in Sjögren's syndrome (SS) as well as the easy accessibility of saliva supports the use of sialometry and sialochemistry in the diagnosis of SS....